Cambridge Financial Group’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-17,908
Closed -$7.07M 33
2021
Q3
$7.07M Sell
17,908
-915
-5% -$421K 3.11% 22
2021
Q2
$8.66M Sell
18,823
-174
-0.9% -$70.1K 3.7% 5
2021
Q1
$7.1M Buy
18,997
+133
+0.7% +$54.2K 3.13% 23
2020
Q4
$6.79M Buy
18,864
+1,640
+10% +$523K 3.23% 18
2020
Q3
$5.18M Sell
17,224
-1,645
-9% -$567K 2.72% 26
2020
Q2
$6.8M Sell
18,869
-257
-1% -$82.7K 3.83% 7
2020
Q1
$5.08M Buy
19,126
+781
+4% +$218K 3.43% 17
2019
Q4
$5.92M Buy
18,345
+1,177
+7% +$357K 3.01% 23
2019
Q3
$5.08M Sell
17,168
-1,819
-10% -$536K 2.76% 29
2019
Q2
$6.8M Buy
18,987
+113
+0.6% +$35.7K 3.62% 8
2019
Q1
$5.7M Buy
18,874
+4,431
+31% +$1.29M 3.09% 20
2018
Q4
$4.21M Buy
+14,443
New +$4.47M 2.69% 23

Other funds holding ILMN

Cambridge Financial Group's ILMN Position: Q4 2021 in Review

Cambridge Financial Group sold out of Illumina (ILMN) in Q4 2021, closing a stake of 17,908 shares — an estimated $7.07M sold.

Cambridge Financial Group first reported a position in ILMN in Q4 2018 and held it in 12 quarters. The position peaked at $8.66M in Q2 2021. 1,067 funds tracked by Wall St. Rank hold ILMN as of Q4 2021.

  • Cambridge Financial Group reported no remaining Illumina position as of Q4 2021 after selling out during the quarter.
  • Cambridge Financial Group sold 17,908 Illumina shares in Q4 2021, an estimated $7.07M.
  • Cambridge Financial Group first reported a position in Illumina in Q4 2018 and held it in 12 quarters.
  • Cambridge Financial Group's Illumina position peaked at $8.66M in Q2 2021.
  • 1,067 funds tracked by Wall St. Rank held Illumina as of Q4 2021.

Based on Cambridge Financial Group's 13F filing for Q4 2021, filed 11 Feb 2022.